TIAA CREF Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
$16.2M Sell
130,215
-626
-0.5% -$74.9K 0.12% 71
2016
Q4
$15.1M Sell
130,841
-14,163
-10% -$1.58M 0.12% 77
2016
Q3
$15.2M Buy
145,004
+13,402
+10% +$1.45M 0.13% 73
2016
Q2
$13M Buy
131,602
+18,732
+17% +$1.94M 0.12% 78
2016
Q1
$11.3M Buy
112,870
+11,615
+11% +$1.2M 0.11% 83
2015
Q4
$12.1M Buy
101,255
+20,933
+26% +$2.42M 0.12% 83
2015
Q3
$8.69M Buy
80,322
+4,347
+6% +$539K 0.1% 99
2015
Q2
$8.79M Buy
75,975
+23,203
+44% +$2.65M 0.1% 102
2015
Q1
$6.08M Buy
52,772
+1,922
+4% +$230K 0.07% 123
2014
Q4
$5.69M Buy
50,850
+4,138
+9% +$436K 0.07% 122
2014
Q3
$4.43M Buy
46,712
+12,142
+35% +$1.1M 0.06% 129
2014
Q2
$2.97M Buy
+34,570
New +$2.63M 0.04% 150

Other funds holding CELG

TIAA CREF Trust's CELG Position: Q1 2017 in Review

TIAA CREF Trust reduced its Celgene Corp (CELG) stake by 0.48% in Q1 2017, selling an estimated $74.9K and leaving 130,215 shares worth $16.2M. The position accounts for 0.12% of the portfolio, ranked #71.

TIAA CREF Trust first reported a position in CELG in Q2 2014 and has held it in 12 quarters since. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

  • TIAA CREF Trust held 130,215 shares of Celgene Corp worth $16.2M as of Q1 2017.
  • TIAA CREF Trust sold 626 Celgene Corp shares in Q1 2017, an estimated $74.9K.
  • Celgene Corp made up 0.12% of TIAA CREF Trust's portfolio in Q1 2017, its #71 holding.
  • TIAA CREF Trust first reported a position in Celgene Corp in Q2 2014 and has held it in 12 quarters since.
  • 1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on TIAA CREF Trust's 13F filing for Q1 2017, filed 3 May 2017.